Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

April 14, 2025 by Projesh Kar

[ad_1]

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly a lift.

[ad_2]

Projesh Kar

I am a passionate blogger with extensive experience in web design. As a seasoned YouTube SEO expert, I have helped numerous creators optimize their content for maximum visibility.

Contact